A Strong European API Industry Can Achieve Strategic Autonomy of the EU Health System

New pricing models for generic medicines to ensure long-term healthy competitiveness in Europe

Scientific advice for continuous innovation in known molecules

Removing access barriers in Central and Eastern Europe – April 2022

Eco-Pharmaco-Stewardship (EPS) initiative – Care for People and Our Environment

VALUE ADDED MEDICINES ONLINE SUMMIT Empowering the healthcare community by improving existing treatments

Biosimilar Medicine Market Review 2020

Market Review – European Generic Medicine Markets 2020

Electronic product information: from principles to actions. AESGP, EFPIA and Medicines for Europe reflections on EMAHMA – EC Key principles for electronic product information

Filling the gap: How off-patent medicines can improve the equity and quality of cancer care